Skip to main content
ACTG logo

ACTG · Acacia Research Corp

Track ACTG — free
$4.34 -0.02 (-0.46%) At close · Oct 2
Market Cap
$421.09M
Shares
97.59M
Volume · Oct 2 126.92K Avg daily vol (3M) 227.04K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$4.34 Open$4.37 Day$4.32–4.38 52W close$3.20–5.16 Avg vol 30d180K Short int2.0M · 2.1% float · 11.8d Short vol61% Last earningsAug 5, 2026 DataJan 2020–Oct 2026 Filing10-Q · Aug 6

Up next

Next earnings call
Nov 4, 2026 Est · unconfirmed · in 4 wks
filed Aug 6, 2026
call held Aug 5, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$278.37M
Trailing 12 months
Net income (TTM)
−$15.01M
Trailing 12 months
Revenue growth YoY
+123.6%
Year over year
Operating margin
-7.0%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+1.9%
Year over year · more shares
Price change (1Y)
+35.6%
Trailing year
Short interest
2.1%
Latest settlement · 11.8 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Neutral Momentum Weak Sentiment Neutral Fundamentals Strong Quant / Vol Moderate
Market backdrop VIX 15.3 · calm Equity put/call 0.58
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg −3%
below
Price vs 50-day avg −4%
below
RSI (14) 41
neutral
MACD trend Negative
52-week position 58%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Weak
1-month return −4%
trailing
6-month return −13%
trailing
YTD return +16%
this year
Relative strength −25%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $5 › 200d $4 — 50d above 200d
Institutional flow Accumulating
1 of 123 funds reported for Sep 30 · net +363 sh shares · +1 new
Insider flow Distributing
Net -$457.6K over 90 days · 100% sells
Short interest Rising
2.10% of float · ▲ +1.0% MoM · 11.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
123 holders — near 3-yr high, broad support
Squeeze score 57
elevated · 0–100
Fundamentals
Strong
Revenue growth −60%
Y/Y
Gross margin 704%
expanding
EPS growth +161%
Y/Y
Free cash flow $-73.4M
Buyback $6.0M
remaining
Balance sheet $214.8M
net cash
Quant / Vol
risk profile
Moderate
Volatility 37%
annualized · 1-yr
Max drawdown −17%
past year
ATR 2.4%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Neutral
1 · 6 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−3% Neutral
Price vs 50-day avg
−4% Neutral
RSI (14)
41 Neutral
MACD trend
Negative Bearish
52-week position
58% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $5 › 200d $4 — 50d above 200d
Institutional flow Accumulating
1 of 123 funds reported for Sep 30 · net +363 sh shares · +1 new
Insider flow Distributing
Net -$457.6K over 90 days · 100% sells
Short interest Rising
2.10% of float · ▲ +1.0% MoM · 11.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
123 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $3 Now $4 · 58% Range high $5
vs 200-day avg -3% vs 50-day avg -4%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Licensing and enforcement programs generating revenues 3 Three Months Ended June 30, 2026 filing —
New license agreements executed 2 Three Months Ended June 30, 2026 filing —
Total production (boe) 547,083 Three Months Ended June 30, 2026 filing —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Business Equipment & Supplies — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
ACTG
Acacia Research Corp
this stock
$421.09M +16.0% -59.7% — 2.1%
CXT
Crane NXT, Co.
$2.71B +3.6% -1.0% 19.5 13.9%
XRX
Xerox Holdings Corp
$424.08M +27.4% +12.9% — 30.4%
ACCO
ACCO BRANDS Corp
$395.08M +15.3% -8.5% 6.9 7.5%
EHGO
EShallGo Inc.
$5.21M — +21.1% — 3.2%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
124
% held
88.2%
Reported
1 of 123
Top holder
Starboard Value LP
Held Float
View
Held by Funds
Fund positions
123
View
Short & Settlement
Short Interest Rising
Shares short
2.0M
Days to cover
11.8d
Change
+19.3K sh
View
Short Volume
Short vol %
61%
As of
Oct 2, 2026
Short Total
View
Fails to Deliver
FTD shares
1.1K
Value
$4.9K
As of
Sep 11, 2026
View
Off-Exchange
Off-exchange %
42.0%
Week of
Aug 24, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$457.6K
Buyers / Sellers
0 / 2
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$285.2M
Net income (FY)
$21.7M
EPS diluted
$0.22
View
Buybacks
Authorized
$40.0M
Remaining
$6.0M
Spent Remaining
View
Filings
SEC Filings
Latest
10-Q
Filed
Aug 6, 2026
This year
9
View
Proposed Sales
Value
$110.0K
Shares
24.0K
Filed
Sep 15, 2026
View
Earnings & Events
Webcasts
Last webcast
Aug 5, 2026
View

Performance

5D 20D 120D MTD YTD
ACTG +1.6% -3.8% -13.2% +0.7% +16.0%
SPY -0.2% -0.5% +12.2% +0.9% +12.9%
vs SPY +1.9% -3.3% -25.4% -0.2% +3.2%

Capital returns

Buyback program · as of Nov 7, 2024
Authorized
$40.00M
Spent (derived)
$34.00M
Remaining
$6.00M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 934549 CUSIP 003881307 13F (30d) 3 filings 3 filers Visit website Investor relations